Skip to main content
 John Lowe

John Lowe

Trial Manager


I am a Research Associate within the Infections, Inflammation and Immunity division at the Centre for Trial Research. Having worked in clinical research within industry, the NHS and academia since completing my undergraduate degree in 2003, I joined Cardiff University in 2011.

Currently I am Trial Manager for the "Azithromycin Therapy for Chronic Lung Disease of Prematurity" trial (AZTEC) which is enrolling infants from neonatal units across the UK.

My clinical background is largely in respiratory medicine, specifically in paediatrics and neonates. I completed my PhD at Cardiff University in 2017 investigating respiratory outcomes in children who were born prematurely, using data from large longitudinal cohort studies. I have successfully co-ordinated a number of clinical trials over the past 15 years.


Education and qualifications

Apr 2012- Mar 2017: Cardiff University

PhD: The role of foetal/infant growth and physical activity in respiratory outcomes of prematurity

2000-2003: Lancaster University/Oregon State University

BSc (Hons): Biological Sciences

Career Overview

2019-Present: Research Associate/Trial Manager, Cardiff University

2018-December 2018: Post-doctoral research associate, Cardiff University

Aug 2017-March 2018: Research Governance Officer, Cardiff University

Nov 2011-Aug 2017: Research Manager/PhD Student, Cardiff University

July 2007-Oct 2011:  Clinical Trial Co-ordinator, University of Liverpool

Feb 2007- Jun 2007:  Research Assistant, University of Manchester

Jan 2006-Jan 2007: Technician/Trial Co-ordinator, North West Lung Centre

Oct 2004-Dec 2005: Senior Clinical Research Technician, Medeval ICON Limited

Oct 2003-Sept 2004: Clinical Research Technician, Medeval ICON Limited










My research interests stem from my clinical trials experience and themes from my PhD, and relates to mechanisms of lung disease in the neonatal period and the impact upon respiratory health in childhood. I have a continuing interest in respiratory disease in children and adults including the management of asthma.

I have obtained funding as a co-applicant from the MRC and NIHR and welcome the opportunity to participate in new collaborations.